Placebo practice trials: the best predictor of adherence readiness for HAART among drug users?
These findings suggest that a brief placebo practice trial has the potential to provide clinicians and patients with an accurate screening tool for evaluating adherence readiness.
The mean difference in REE between MG and DT was relatively small (103 kcal/d) but significant; however, a portion of this difference may have been related to differences in subject positioning. These preliminary data indicate that the MG shows promise as a valid tool in the assessment of REE in children.